|
ES2390439A1
|
|
injectable composition
|
|
ES2445494A1
|
|
Procedure for obtaining low and very low molecular weight heparins
|
|
EP2529756A2
|
|
Risperidone and/or Paliperidone implant formulation
|
|
EP2529757A1
|
|
Paliperidone implant formulation
|
|
ES2357601A1
|
|
PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF GLYCONAMINOGLYCAN DONORS OF NORTIC OXIDE AND ITS USE IN THE TREATMENT OF CHRONIC ULCERS.
|
|
EP2394663A1
|
|
Compositions for injectable in-situ biodegradable implants
|
|
EP2213282A1
|
|
Pharmaceutical forms for the release of active compounds
|
|
ES2336297A1
|
|
PENTASACARIDOS SYNTHESIS PROCEDURE DEPROTECTED FROM A PENTASACARIDO PRECURSOS PROTECTED.
|
|
ES2340902A1
|
|
PHARMACEUTICAL COMPOSITION WITH GLYCAMINOGLYGANS AND ITS USE IN THE TREATMENT OF CHRONIC ULCERAS.
|
|
EP2060253A1
|
|
Pharmaceutical forms for the release of active compounds
|
|
ES2296529A1
|
|
PHARMACEUTICAL COMPOSITION WITH ABSORPTION PROMOTERS.
|
|
ES2292351A1
|
|
NEW PROCEDURE FOR DEPOLIMERIZATION OF HEPARINE.
|
|
ES2222822A1
|
|
DIAMIDES OF AMINO ACIDS IN NON-ALFA POSITION USEFUL AS ASSISTANTS FOR THE ADMINISTRATION OF ACTIVE BIOLOGICAL AGENTS.
|
|
EP1313453A1
|
|
Particulate vectors for improving oral absorption of active principles
|
|
ES2172461A1
|
|
NEW LIGHTS OF GD (III) WITH BI-Y BIS-AZOLICA STRUCTURES.
|
|
ES2161615A1
|
|
Compositions of heparins of very low molecular weight.
|
|
ES2048090A1
|
|
Procedure for the obtaining of new antitromboticos derived from cumarina.
|
|
ES2003197A6
|
|
Process for the depolymerization of heparin for obtaining heparin with a low molecular weight and having an antithrombotic activity.
|
